SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-16-006431
Filing Date
2016-03-02
Accepted
2016-03-02 16:05:33
Documents
3
Period of Report
2016-03-02
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT opxa_8k.htm 8-K 31954
2 CERTIFICATION opxa_ex991.htm EX-99.1 13435
3 opexalogo.jpg GRAPHIC 5111
  Complete submission text file 0001354488-16-006431.txt   54136
Mailing Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381
Business Address 2635 TECHNOLOGY FOREST BLVD. THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33004 | Film No.: 161477106
SIC: 2834 Pharmaceutical Preparations